Sotera Health Company (SHC) SEC Filings & Earnings Calls

Inflationary cost pressures partially offset by pricing.

“Segment income benefited from pricing and volume/mix, partially offset by inflation.”

Foreign currency exposure.

“Constant currency adjustments; foreign currency benefit of ~100 bps in guidance.”

Ethylene Oxide Tort Litigation

“Professional services relating to EO sterilization facilities (e) Represents litigation and other professional fees associated with our EO sterilization facilities.” · word for word

High Leverage

“Long-term debt $2,125,534”

Soft call premium of 1.00% for certain repricing transactions within six months may limit near-term refinancing flexibility.

“The Repriced Term Loans are also subject to a “soft call” premium of 1.00% for certain repricing transactions with respect to the Repriced Term Loans that occur within the six-month period after the effective date of the Amendment.”

EO Litigation Exposure

“On April 3, 2025, the Company agreed to resolve 97 pending and threatened EO claims in the State of Illinois. Pursuant to the terms of the term sheet, the Company agreed to pay $30.9 million to settle the claims.” · word for word

Nelson Labs Volume Decline

“Nelson Labs net revenues $51.9 million, a decrease of $0.4 million, or 0.7%”

CEO transition risk, though planned and with overlap period; new CEO's integration and strategic direction uncertain.

“Michael B. Petras, Jr. will transition from his role as CEO... Mr. Shader... has served as Chief Executive Officer... of Viant Medical, LLC.”

Ethylene Oxide (EO) Litigation Exposure

“The EO Litigation Committee was formed in October 2022 to oversee the Company’s management of litigation involving EO. The EO Litigation Committee monitors litigation developments, oversees our overall litigation strategy and reports to and makes recommendations to the Board as may be warranted. The EO Litigation Committee met eight times in 2025.” · word for word

Sponsor Ownership Concentration and Secondary Offering Dilution

“Following this sale, after taking into account other sales made on an unregistered basis, Warburg Pincus and GTCR’s beneficial ownership of our outstanding common stock was reduced to 6.72% and 4.48%, respectively.” · word for word

Key Person Retention Risk (CFO)

“In February 2025, the Board approved a special cash award to Mr. Lyons to help encourage his long-term retention and to promote continued alignment with the Company’s long-term objectives. Mr. Lyons was granted a cash award of $500,000 which will vest in four installments ... In February 2025, the Board also approved a special grant of $500,000 in time-based” · word for word

General Counsel Retirement

“Alexander Dimitrief (1) SVP and General Counsel (1) Mr. Dimitrief retired from the Company effective March 31, 2026.” · word for word

Regulatory compliance cost from EO emission rules

“For 2026, we expect capital expenditures of approximately $51 million related to environmental facility enhancements across all facilities within our business, and we anticipate continuing to invest in environmental facility enhancements in the future.” · word for word

Co-60 supply variability

“Our access to Co-60 tends to vary on a quarterly basis, due primarily to nuclear reactor maintenance schedules, the length of time required to convert Co-59 into Co-60, the limited number of facilities that can generate Co-60 in an economically efficient manner, and the timing of the removal of Co-60 from reactors.” · word for word

High debt levels and refinancing risk

“Our cash flows may not be sufficient to service our indebtedness, and if we are unable to satisfy our obligations under our indebtedness, we may be required to seek other financing alternatives, which may not be successful.” · word for word

Litigation and regulatory investigations

“developments in our litigation matters and governmental investigations or additional significant lawsuits or governmental investigations relating to our services or facilities” · word for word

Ethylene oxide litigation exposure; General Counsel retiring but retained as advisor for litigation matters.

“Mr. Dimitrief is expected to be retained by the Company as an advisor to assist the Company with ethylene oxide litigation matters.” · word for word

Risks related to EO supply, litigation, and regulatory changes

“Forward-looking statements highlight risks including disruption in availability or supply of EO, Co-60 or other direct materials, and impact of litigation related to EO emissions.”

Secondary offering may indicate selling stockholder desire to exit; no company proceeds.

“Sale of 30M shares by selling stockholders; company receives no proceeds.”

EO Litigation Exposure

“Illinois EO litigation settlements... $64.9 million... for the nine months ended September 30, 2025.”

Nelson Labs Revenue Decline

“Nelson Labs net revenues were $55.7 million... decrease of $2.9 million, or 5.0%.” · word for word

Ethylene oxide litigation settlements totaling $65M; ongoing legal exposure.

“Net income was $43 million, which includes the previously disclosed settlement of approximately $31 million and the pending settlement of $34 million related to ethylene oxide (“EO”) claims against Sterigenics”

Nelson Labs revenue decline 5.0% due to decline in expert advisory services.

“Nelson Labs net revenues decreased 5.0% to $56 million; driven by a decline in expert advisory services revenues.” · word for word